Lebwohl, M., J.-P. Lacour, M. Liljedahl, C. Lynde, M. H. M?rch, D. Tha?i, and R. B. Warren. “Safety of Long-Term Proactive Management With Fixed-Dose Combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam in Patients With Psoriasis Vulgaris: Results of a Phase III, Multicentre, Randomized, 52-Week, Vehicle-Controlled Trial”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s31, doi:10.25251/skin.4.supp.31.